RETRACTED: Microarray analysis of microRNA expression in liver cancer tissues and normal control

Gene

Volumn 523, Issue 2, 2013, Pages 158-160

  Lin, Lianjie ^a   Lin, Yan ^a   Jin, Yu ^a   Zheng, Changqing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Hsa miR 421; Liver cancer; MiRNA analysis

Indexed keywords

MICRORNA; MICRORNA 15B; MICRORNA 1975; MICRORNA 199A 3P; MICRORNA 199B 3P; MICRORNA 421; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER TISSUE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE MAPPING; HUMAN; HUMAN GENOME; HUMAN TISSUE; LIVER; LIVER CANCER; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; CHROMOSOME MAP; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME MAPPING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; LIVER NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

MLCS; MLOWN;

EID: 84880445150     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.02.055     Document Type: TB

References (28)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Basyuk E., Suavet F., Doglio A., Bordonné R., Bertrand E. Human let-7 stem-loop precursors harbor features of RNase III cleavage products. Nucleic Acids Res. 2003, 31:6593-6597.
3. Calin G.A., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. 2002, 99:15524-15529.
4. Chan S.K., Griffith O.L., Tai I.T., Jones S.J.M. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol. Biomark. 2008, 17:543-552.
5. Chen R., et al. Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells. Oncogene 2008, 27:4712-4723.
6. Coulouarn C., Factor V., Andersen J., Durkin M., Thorgeirsson S. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009, 28:3526-3536.
7. Eifert C., Powers R.S. From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets. Nat. Rev. Cancer 2012, 12:572-578.
8. Fornari F., et al. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2010, 70:5184-5193.
9. Hao J., Zhang S., Zhou Y., Liu C., Hu X., Shao C. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem. Biophys. Res. Commun. 2011, 406:552-557.
10. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992, 71:543.
11. He L., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
12. Henry J.C., et al. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 2010, 403:120-125.
13. Hiroki E., et al. Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci. 2010, 101:241-249.
14. Hou J., et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer cell 2011, 19:232-243.
15. Huang X.H., et al. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J. Pathol. 2011, 225:463-472.
16. Jiang Z., et al. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J. Gastroenterol. 2010, 45:17-23.
17. Kusenda B., Mraz M., Mayer J., Pospisilova S. MicroRNA biogenesis, functionality and cancer relevance. Biomed. Pap. 2009, 150:205-215.
18. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
19. Lee Y., Jeon K., Lee J.T., Kim S., Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002, 21:4663-4670.
20. Li R., Li Y., Kristiansen K., Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics 2008, 24:713-714.
21. Liang L., et al. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 2010, 52:1731-1740.
22. Sarver A.L., et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC cancer 2009, 9:401.
23. Wen J., Friedman J.R. miR-122 regulates hepatic lipid metabolism and tumor suppression. J. Clin. Invest. 2012, 1.
24. Xia H., et al. MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem. Biophys. Res. Commun. 2009, 380:205-210.
25. Yi X., et al. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol. Cell. Proteomics 2008, 7:315-325.
26. Youssef Y.M., et al. Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur. Urol. 2011, 59:721-730.
27. Yu S., et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 2012, 97:2084-2092.
28. Zhang Y., et al. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Mol. Cancer Res. 2012, 10:516-522.